By Rebekah Ninan This summer, a startling study from researchers at University of California, Berkeley revealed tampons from several brands contain toxic heavy metals like lead, arsenic, and cadmium. This finding follows the 2023 discovery that many menstrual products contain per- and polyfluoroalkyl substances (PFAS), even those marketed as PFAS-free. All of these contaminants are…
By Rebekah Ninan This past month, California Governor Gavin Newsom signed a wave of artificial intelligence-related legislation into law. Much public debate has been focused on SB 1047, a proposal ultimately vetoed by Governor Newsom, which would have held AI companies liable for “catastrophic harms” from AI models. Comparatively little attention has been paid to…
This post launches a Digital Symposium on The Future of Telehealth Regulation, edited by Carmel Shachar, Assistant Clinical Professor of Law and Faculty Director of the Health Law and Policy Clinic at the Center for Health Law and Policy Innovation. The symposium continues the conversation from a working group held in June 2023 titled “Achieving…
By Karina Bashir The law helps establish legitimacy and inform societal norms—a role that becomes particularly pronounced in the field of psychedelics. Lingering stigma from the War on Drugs, despite the promising scientific potential of psychedelics, hinders the growth of the psychedelic industry and its public acceptance. The public’s trepidation is reflected in a…
A whole-person response to OUD and other substance use disorders needs a well-coordinated whole-of-government response.
Shovel-ready actions that could be taken to support the harm reduction response to the opioid crisis.
Shovel-ready actions that could be taken to reimagine drug policing response to the opioid crisis.
Highlighting legal opportunities to facilitate access to opioid use disorder (OUD) treatment.
State litigation and legislation has created a landscape of uncertainty surrounding the legal status of the federal COVID-19 vaccine mandate.
The parity framework has proven less adept at rooting out more subtle forms of disparities in mental health coverage restrictions.
